Featured

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

North America Session – From reaction to result: Connecting chemistry and biology for smarter drug discovery

A molecule passes through many hands in drug discovery. Medicinal chemists design and synthesise it, analytical scientists characterise it, and biology teams evaluate its activity. Yet the scientific knowledge generated along the way often remains fragmented across disconnected systems, making it difficult to connect what was made, how it was… Read More

Webinar date:
Supported by Benchling
#Featured Webinars #Webinars

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Europe Session – From reaction to result: Connecting chemistry and biology for smarter drug discovery

A molecule passes through many hands in drug discovery. Medicinal chemists design and synthesise it, analytical scientists characterise it, and biology teams evaluate its activity. Yet the scientific knowledge generated along the way often remains fragmented across disconnected systems, making it difficult to connect what was made, how it was… Read More

Webinar date:
Supported by Benchling
#Featured Webinars #Webinars

#Biomarkers #Drug discovery #Evotec #Immunoassays #Webinar

Measuring what matters: Applying ultrasensitive immunoassays for clinical biomarkers

When biomarkers are present at very low concentrations, conventional immunoassays may not provide the sensitivity needed to generate reliable, meaningful data. This can limit the ability to assess target engagement, monitor pharmacodynamic responses and track biomarker changes during treatment. Ultrasensitive immunoassays offer new opportunities to address these challenges. In this… Read More

Webinar date:
Supported by Evotec
#Featured Webinars #Webinars

#Crown Bioscience #Drug discovery #PDX models #Webinar

Beyond the model: Exploring warm PDX benefits and onsite expertise

Patient-derived xenograft (PDX) models are a valuable tool in oncology research, helping researchers evaluate therapeutic efficacy in preclinical settings using models that retain key characteristics of human tumours. In this webinar, Crown Bioscience will highlight the capabilities of its PDX model portfolio, with a particular focus on the benefits of… Read More

Webinar date:
Supported by Crown Bioscience
#Featured Webinars #Webinars

#Biomarkers #Drug discovery #Evotec #Webinar

From PK/PD and Biomarkers to decision-making: How modeling shapes clinical strategy

Clinical trials continue to experience high attrition rates, with lack of efficacy being one of the leading causes of failure. However, in many cases, these failures do not reflect a lack of drug efficacy, but rather limitations in translational biomarker strategies and selection of disease-relevant pharmacodynamic (PD) biomarkers, suboptimal dose… Read More

Webinar date:
Supported by Evotec
#Featured Webinars #Webinars

Cell and gene therapy
#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy

Advances and challenges in cell and gene therapies

Hosted by Drug Discovery World and supported by Bio-Techne, this webinar explores the advances and challenges taking place within the cell and gene therapy field. Hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo Therapeutics. Throughout the… Read More

Webinar date:
Sponsored by Bio-Techne
#Featured Webinars

Webinars

#Cell and gene therapy #Drug development #Drug discovery

Cell and gene therapy: sustaining growth and maximising opportunities

Cell and gene therapies are transforming the way diseases are treated. As research progresses it is hoped that cell and gene therapies will offer innovation for the future. In this on-demand webinar you will hear from CBO/CDO of Adthera Bio, Stuart Curbishley, Chief Executive Officer of Cell & Gene Therapy… Read More

Webinar date:
Sponsored by Benchling and BPS Bioscience
#Webinars

CAR-T cells attack cancer cells
#Cancer research #CAR-T #Cell and gene therapy #Cell therapy #High throughput screening #Immunotherapy #T cell activation

Improving cell therapies with high-throughput CAR libraries

CAR-T cell therapies are a promising approach for treating solid tumours. But identifying appropriate T-cell receptor (TCR) domains that exclusively target tumour antigens remains a challenge. Toxicity, tumour activation, and tumour persistence are significant challenges to using CAR-T cell therapies for solid tumours. In this webinar, Twist Bioscience’s CSO, Aaron… Read More

Webinar date:
Brought to you by Twist Bioscience
#Webinars

IgE antibodies
#Allergy #Antibody discovery workflow #Engineered antibodies #Genomics #IgE antibodies #Immunotherapy #Monoclonal antibodies

Harnessing the power of IgE antibodies to create novel therapeutics

From human B cells to engineered antibodies, IgGenix is taking a novel approach towards breaking through the last frontier of immunology: allergies. By reengineering key antibodies in the allergic cascade, this biotech company is developing a first-in-class therapy for the millions of people whose daily lives are limited by food… Read More

Webinar date:
Brought to you by SPT Labtech
#Webinars

#Antibody discovery workflow #B cell diversity #Monoclonal antibodies

Accessing broad B cell diversity to rapidly identify high-value rabbit monoclonal antibodies

Opto B Discovery on the Beacon optofluidic system is designed to enable rapid selection of lead candidates by function-forward screening of B cells in under one week. This presentation will introduce Berkeley Lights’ newest antibody discovery workflow, the Opto Memory B Discovery workflow, and share how customers are using the… Read More

Webinar date:
Brought to you by Berkeley Lights
#Webinars

#Biopharmaceuticals #Cell line development #Cell lines #Picodroplet technology #Single cell sorter #Single-cell analysis

Embedding quality into cell line development through the application of an innovative picodroplet-based single cell sorter

Generation of a highly expressing, regulatory acceptable clonal cell line is the first key activity in the development of a biopharmaceutical. Cell line development is labour intensive, time consuming and costly and is subject to stringent regulations to ensure patient safety. Dr Jonathan H Dempsey All cell lines used to… Read More

Webinar date:
Brought to you by Sphere Fluidics
#Webinars

Healthy cells
#Biomarkers #Drug discovery #RNA sequencing #Single-cell RNA sequencing

Broadening drug discovery: Use of unperturbed, native state cells to uncover true biological targets at single-cell level

Extensive manipulation, mechanical force, and labelling methods used to enrich cells activate transcriptional programs that mask molecular profiles truly significant to any underlying disease. The consequence is identification of drug targets that are not relevant to the biological process under study. Based on Nakhoda and Olszanski, 2022 (Addressing Recent Failures… Read More

Webinar date:
Brought to you by LevitasBio
#Webinars

Cell and gene therapies
#Cell and gene therapy #mRNA #pDNA #Webinar

Early phase support for plasmid DNA supply to secure future manufacturing

One critical bottleneck in Cell and Gene Therapy (CGT) manufacturing is the production of high-quality plasmid DNA (pDNA), a vital building block for mRNA-based vaccines, viral vector-based cell or gene therapies that require pDNA as a starting material. Building a robust supply of GMP-grade pDNA requires that quality be a… Read More

Webinar date:
Brought to you by Catalent
#Webinars

#Cell engineering #CRISPR #Gene editing #Target discovery #Target identification #Target validation

Reveal the best drug targets with Engineered Cell Libraries

CRISPR-based knockouts are the gold-standard genetic perturbation method in target identification and validation. However, efficient CRISPR knockout editing and transfection for arrayed screening require specialised skills and infrastructure that your organisation may not have. What if you could receive ready-to-use CRISPR-edited cells without needing to handle, optimise, and transfect your… Read More

Webinar date:
Brought to you by Synthego
#Webinars

Neurons in the brain
#Drug discovery #In vitro assays #Multiple sclerosis #Neurodegenerative disorders #Neuronal damage #Target identification #Webinar

Innovative assays for neurodegeneration drug discovery programs

Neurodegenerative diseases are characterised by neuronal damage, degradation of the blood-brain barrier and failures in the normal repair mechanisms of the brain. Many of the most promising areas of drug development in this field target neuroinflammation and remyelination. In this on-demand webinar, presented by Dr Elise Malavasi, Principal Scientist at… Read More

Webinar date:
Brought to you by Malvern Panalytical
#Webinars

#cryo-microscopy #Drug discovery #Webinar

High resolution electron cryo-microscopy: From membrane proteins to diseases

Watch the webinar High resolution electron cryo-microscopy: From membrane proteins to diseases, supported by Thermo Fisher Scientific.  The webinar demonstrates how cryo-EM is impacting high resolution structure biology from membrane proteins to diseases including Alzheimer’s disease and cancer therapeutics by showing high-resolution structures of these… Read More

Webinar date:
Brought to you by Thermo Fisher Scientific
#Webinars

#cryo-microscopy #Drug discovery #Webinar

Utilising novel sample preparation techniques to enhance Cryo-EM structural analysis 

Cryo-EM has been adopted into drug discovery workflows by the pharmaceutical and biotechnology industries having proved itself capable of delivering atomic resolution structures for key targets, including integral membrane proteins such as GPCRs and ion channels.   More recently, significant improvements in throughput have seen use of the… Read More

Webinar date:
Brought to you by SPT LabTech
#Webinars

Molecules
#Drug discovery #Fragment-based drug discovery #Hit identification #Webinar

An introduction into fragment-based drug discovery: webinar

Fragment-based drug discovery (FBDD) is a method used for finding hit compounds as one strategy of hit identification (hit ID) in the drug discovery process.   Introduction into Fragment Based Drug Discovery, hosted by DDW and supported by WuXi AppTec, is now available to watch online. … Read More

Webinar date:
Brought to you by WuXi AppTec
#Webinars

#Biosensors #Drug discovery #Webinar

Tips and Tricks on Obtaining Quality Data from Biosensors for Cell Signalling Assays

Tips and tricks on how to obtain and analyse high quality data from live cell, high throughput assays of signaling dynamics. Genetically encoded fluorescent biosensors enable continuous recording of cellular signaling in live cells. This breakthrough technology provides unprecedented, real-time measurements of signaling dynamics, which is emerging as a critical… Read More

Webinar date:
Brought to you by Agilent BioTek
#Webinars

#Antibody reagents #Drug discovery #Monoclonal antibodies #Webinar

High throughput Octet BLI applications in early monoclonal antibody discovery

Charles River, Antibody Discovery group, has integrated computational immunology, antibody engineering and phage display technologies into its comprehensive antibody discovery platforms that rapidly deliver antibody hits or optimised variants with a range of affinities, cross-species coverage, and improved drug-like characteristics. Charles River uses label-free biosensors and other bioanalytical assays to… Read More

Webinar date:
Brought to you by Sartorius
#Webinars

#AI / data analytics / healthtech / informatics #Laboratory #Webinar

Transforming lab automation for cellular applications

Automation has long been a buzzword associated with cutting-edge science, yet even in the most advanced labs it is usually only applied to specific assays and methods. However, by building automation across your full laboratory workflows and integrating it into existing protocols, Biotech R&D can be transformed. In this webinar, titled… Read More

Webinar date:
Brought to you by Automata Technologies
#Webinars

#Biology #Genetics / genomics #Single-cell analysis #Webinar

Resolving complex biology with single cell and spatial multiomics

Single cell and spatial tools from 10 X Genomics are designed to deliver powerful, multiomic insights from complex disease samples that enable you to confidently fuel your target identification pipeline with the most promising candidates. Resolving complex biology with single cell and spatial multiomics was presented by Stephen Hague, Managing… Read More

Webinar date:
Brought to you by 10 X Genomics
#Webinars